Cholecystitis after yttrium-90 resin microsphere radioembolization treatment: Clinical and pathologic findings [PDF]
Background: Radioembolization with yttrium microspheres is an established therapeutic modality for primary and secondary hepatic malignancies, with studies demonstrating improved overall survival.
Desmond Yip +2 more
exaly +6 more sources
Side Effects of Yttrium-90 Radioembolization [PDF]
Limited therapeutic options are available for hepatic malignancies. Image guided targeted therapies have established their role in management of primary and secondary hepatic malignancies.
Riad Salem, Ahsun Riaz, Salem Riad
exaly +4 more sources
Complications of Radioembolization: Prevention and Management [PDF]
Radioembolization is a relatively safe procedure, and most adverse effects are part of the post-embolization syndrome, which includes symptoms such as abdominal pain and fatigue.
Gyoung Min Kim
doaj +5 more sources
Factors associated with contralateral liver hypertrophy after unilateral radioembolization for hepatocellular carcinoma. [PDF]
Radioembolization for the treatment of hepatocellular carcinoma (HCC) induces liver volume changes referred to as "atrophy-hypertrophy complex". The aim of this study was to investigate lobar liver volume changes after unilateral radioembolization and to
Juliane Goebel +8 more
doaj +3 more sources
Laparoscopic right hepatectomy for hepatocellular carcinoma after sequential yttrium-90 liver radioembolization and liver venous deprivation (with video) [PDF]
Laparoscopic right hepatectomy has gained acceptance for major oncologic hepatectomies. Preoperative sequential strategies for induced tumor downsizing and contralateral liver hypertrophy ensure the safety of these major hepatectomies, especially in ...
Pierre De Mathelin, Pietro Addeo
doaj +2 more sources
Can non-tumorous liver tissue serve as a reliable reference measure for [18F]FDG-PET-CT after unilobar 90Y glass radioembolization in patients with colorectal liver metastases? [PDF]
Background Effect of radiation on [18F]FDG-uptake in non-tumorous liver tissue after radioembolization is sparsely investigated, despite the liver being the most common reference for assessment of metabolic response (e.g., PET Response Criteria In Solid ...
Li Shen Ho +5 more
doaj +2 more sources
Patients with recurrent hepatocellular carcinoma (HCC) following liver transplantation (LT) have a poor prognosis owing to rapid tumor progression.
Jian-Wen Zhang +6 more
doaj +1 more source
Gastrectomy for the treatment of refractory gastric ulceration after radioembolization with Y microspheres [PDF]
Transcatheter arterial radioembolization (TARE) with Yttrium-90 (90Y)-labeled microspheres has an emerging role in treatment of patients with unresectable hepatocellular carcinoma.
Sun Young Yim +10 more
doaj +1 more source
Transarterial radioembolization for liver tumors as neoadjuvant therapy: three case reports
Transarterial radioembolization (TARE) with yttrium-90 microspheres is a palliative locoregional treatment, minimally invasive for liver tumors. The neoadjuvant aim of this treatment is still controversial, however, selected cases with lesions initially ...
Vithor de Oliveira Carvalho +9 more
doaj +2 more sources
Objective: We aimed to investigate the diagnostic value of diffusion-weighted imaging in assessing liver injury after radioembolization via comparing pre- and post-treatment apparent diffusion coefficient values of nontumoral liver parenchyma in patients
Emine Şebnem Durmaz +5 more
doaj +1 more source

